Monrat Chulanetra

479 total citations
23 papers, 330 citations indexed

About

Monrat Chulanetra is a scholar working on Infectious Diseases, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Monrat Chulanetra has authored 23 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Monrat Chulanetra's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Hepatitis C virus research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Monrat Chulanetra is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Hepatitis C virus research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Monrat Chulanetra collaborates with scholars based in Thailand, United States and Australia. Monrat Chulanetra's co-authors include Wanpen Chaicumpa, Potjanee Srimanote, Jeeraphong Thanongsaksrikul, Nitat Sookrung, Kanyarat Thueng-in, Watee Seesuay, Aijaz Ahmad Malik, Yuwaporn Sakolvaree, William B. Slayton and Joanne Lagmay and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Monrat Chulanetra

23 papers receiving 328 citations

Peers

Monrat Chulanetra

RNMI

GENET

IMMUN

Deborah King United Kingdom

Dmitry V. Shcheblyakov Russia

Maria F. Perdomo Finland

Y. Guédez Venezuela

Jessica Maria Abbate Italy

Joann Vennari United States

Matteo Samuele Pizzuto Italy

Stuart Cox United States

Michelle A. Clark Australia

Deborah King United Kingdom

Monrat Chulanetra

114 ×1.1

103 ×1.1

40 ×0.5

RNMI

50 ×0.8

GENET

134 ×2.6

IMMUN

Citations per year, relative to Monrat Chulanetra Monrat Chulanetra (= 1×) peers Deborah King

Countries citing papers authored by Monrat Chulanetra

Since Specialization

Citations

This map shows the geographic impact of Monrat Chulanetra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monrat Chulanetra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monrat Chulanetra more than expected).

Fields of papers citing papers by Monrat Chulanetra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monrat Chulanetra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monrat Chulanetra. The network helps show where Monrat Chulanetra may publish in the future.

Co-authorship network of co-authors of Monrat Chulanetra

This figure shows the co-authorship network connecting the top 25 collaborators of Monrat Chulanetra. A scholar is included among the top collaborators of Monrat Chulanetra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monrat Chulanetra. Monrat Chulanetra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chulanetra, Monrat, et al.. (2024). Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection. Scientific Reports. 14(1). 27311–27311. 4 indexed citations

Chulanetra, Monrat, et al.. (2023). Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer. Vaccines. 11(12). 1826–1826. 1 indexed citations

Chulanetra, Monrat, et al.. (2023). Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies. Viruses. 15(6). 1252–1252. 2 indexed citations

Srimanote, Potjanee, et al.. (2023). Isolation and Characterization of scFv Antibody against Internal Ribosomal Entry Site of Enterovirus A71. International Journal of Molecular Sciences. 24(12). 9865–9865. 1 indexed citations

Chulanetra, Monrat, et al.. (2023). Human super antibody to viral RNA-dependent RNA polymerase produced by a modified Sortase self-cleave-bacteria surface display system. Microbial Cell Factories. 22(1). 260–260. 1 indexed citations

Sookrung, Nitat, et al.. (2022). Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants. International Journal of Molecular Sciences. 23(12). 6587–6587. 4 indexed citations

Thueng-in, Kanyarat, et al.. (2022). Targeting Emerging RNA Viruses by Engineered Human Superantibody to Hepatitis C Virus RNA-Dependent RNA Polymerase. Frontiers in Microbiology. 13. 926929–926929. 8 indexed citations

Reamtong, Onrapak, Ladawan Khowawisetsut, Poom Adisakwattana, et al.. (2022). Peptide of Trichinella spiralis Infective Larval Extract That Harnesses Growth of Human Hepatoma Cells. Frontiers in Cellular and Infection Microbiology. 12. 882608–882608. 6 indexed citations

Chulanetra, Monrat, et al.. (2022). Enhancing epitope of PEDV spike protein. Frontiers in Microbiology. 13. 933249–933249. 12 indexed citations

10.

Chulanetra, Monrat, et al.. (2021). Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase. Molecules. 26(21). 6436–6436. 5 indexed citations

11.

Chulanetra, Monrat & Wanpen Chaicumpa. (2021). Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites. Frontiers in Cellular and Infection Microbiology. 11. 702125–702125. 39 indexed citations

12.

Chulanetra, Monrat, et al.. (2021). Quantitative PCR to Discriminate Between Pneumocystis Pneumonia and Colonization in HIV and Non-HIV Immunocompromised Patients. Frontiers in Microbiology. 12. 729193–729193. 17 indexed citations

13.

Chulanetra, Monrat, Elias Sayour, Lamis Eldjerou, et al.. (2020). GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas.. PubMed. 10(2). 674–687. 41 indexed citations

14.

Eyre, Nicholas S., Amanda L. Aloia, Michael Joyce, et al.. (2017). Sensitive luminescent reporter viruses reveal appreciable release of hepatitis C virus NS5A protein into the extracellular environment. Virology. 507. 20–31. 19 indexed citations

15.

Chulanetra, Monrat, Aijaz Ahmad Malik, Jeeraphong Thanongsaksrikul, et al.. (2017). Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus. Scientific Reports. 7(1). 15042–15042. 15 indexed citations

16.

Malik, Aijaz Ahmad, Monrat Chulanetra, Jeeraphong Thanongsaksrikul, et al.. (2016). Inhibition of HCV replication by humanized-single domain transbodies to NS4B. Biochemical and Biophysical Research Communications. 476(4). 654–664. 19 indexed citations

17.

Seesuay, Watee, Urai Chaisri, Nitat Sookrung, et al.. (2016). Human transbodies to VP40 inhibit cellular egress of Ebola virus-like particles. Biochemical and Biophysical Research Communications. 479(2). 245–252. 15 indexed citations

18.

Thanongsaksrikul, Jeeraphong, Kanyarat Thueng-in, Monrat Chulanetra, et al.. (2015). Humanized-VHH Transbodies that Inhibit HCV Protease and Replication. Viruses. 7(4). 2030–2056. 35 indexed citations

19.

Chulanetra, Monrat, Elias Sayour, Lamis Eldjerou, et al.. (2015). Abstract 3157: Novel GD2-specific chimeric antigen receptor-modified T cells targeting osteosarcoma. Cancer Research. 75(15_Supplement). 3157–3157. 1 indexed citations

20.

Thueng-in, Kanyarat, Jeeraphong Thanongsaksrikul, Watee Seesuay, et al.. (2014). Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase. mAbs. 6(5). 1327–1339. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact